Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 May;55(5):409–410. doi: 10.1136/jnnp.55.5.409

Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.

S Ueno 1, Y Hara 1
PMCID: PMC489088  PMID: 1318359

Abstract

A 59 year old man with ischaemic heart disease, developed the clinical and electromyographic changes of the Lambert-Eaton myasthenic syndrome after taking calcium antagonist, diltiazem. The symptoms appeared periodically with a rise and fall in serum level of diltiazem. Extensive search was made for systemic neoplasms and autoimmune diseases without success. Serum antibody to voltage operated calcium channel was not detected.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang C. C., Lin S. O., Hong S. J., Chiou L. C. Neuromuscular block by verapamil and diltiazem and inhibition of acetylcholine release. Brain Res. 1988 Jun 28;454(1-2):332–339. doi: 10.1016/0006-8993(88)90834-7. [DOI] [PubMed] [Google Scholar]
  2. Fukunaga H., Engel A. G., Lang B., Newsom-Davis J., Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7636–7640. doi: 10.1073/pnas.80.24.7636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hughes R. L., Katirji M. B. The Eaton-Lambert (myasthenic) syndrome in association with systemic lupus erythematosus. Arch Neurol. 1986 Nov;43(11):1186–1187. doi: 10.1001/archneur.1986.00520110072020. [DOI] [PubMed] [Google Scholar]
  4. Lang B., Newsom-Davis J., Wray D., Vincent A., Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet. 1981 Aug 1;2(8240):224–226. doi: 10.1016/s0140-6736(81)90474-8. [DOI] [PubMed] [Google Scholar]
  5. Lennon V. A., Lambert E. H., Whittingham S., Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1982;5(9S):S21–S25. [PubMed] [Google Scholar]
  6. O'Neill J. H., Murray N. M., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988 Jun;111(Pt 3):577–596. doi: 10.1093/brain/111.3.577. [DOI] [PubMed] [Google Scholar]
  7. Peers C., Lang B., Newsom-Davis J., Wray D. W. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. J Physiol. 1990 Feb;421:293–308. doi: 10.1113/jphysiol.1990.sp017945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sher E., Gotti C., Canal N., Scoppetta C., Piccolo G., Evoli A., Clementi F. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet. 1989 Sep 16;2(8664):640–643. doi: 10.1016/s0140-6736(89)90893-3. [DOI] [PubMed] [Google Scholar]
  9. Tsien R. W., Lipscombe D., Madison D. V., Bley K. R., Fox A. P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988 Oct;11(10):431–438. doi: 10.1016/0166-2236(88)90194-4. [DOI] [PubMed] [Google Scholar]
  10. Wachtel R. E. Effects of diltiazem and verapamil on responses to acetylcholine. Br J Pharmacol. 1987 Nov;92(3):561–566. doi: 10.1111/j.1476-5381.1987.tb11357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Yamada A., Takeuchi H., Touge T., Miki H., Kuwabara H. [Eaton-Lambert syndrome manifested by respiratory failure associated with small cell carcinoma of the lung]. Rinsho Shinkeigaku. 1990 Jul;30(7):780–783. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES